halobetasol/tazarotene (Duobrii)

Indications

• topical treatment of plaque psoriasis

Dosage

lotion; 0.01%/0.045% once daily

Adverse effects

• contact dermatitis (7%)
• application site pain (3%)
• folliculitis (2%)
• skin atrophy (2%)
• excoriation (2%)

Mechanism of action

• combination glucocorticoid/retinoid

More general terms

• pharmacologic combination

Component of

• halobetasol/tazarotene (Duobrii)

Components

• halobetasol/tazarotene (Duobrii)